These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4816800)

  • 1. Serum copper levels and diphenylhydantoin.
    Taylor JD; Krahn PM; Higgins TN
    Am J Clin Pathol; 1974 Apr; 61(4):577-8. PubMed ID: 4816800
    [No Abstract]   [Full Text] [Related]  

  • 2. [Test of stimulation of ceruloplasmin activity and copper concentration as affected by diphenylhydantoin (phenytoin, TSC) in the diagnosis of hepatolenticular degeneration].
    Pakszys W; Ligezińska B; Szymański H
    Pol Tyg Lek; 1982 Nov; 37(45):1353-7. PubMed ID: 7163091
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in ceruloplasmin and serum copper in epileptics].
    Merlo SG; Fernandez Martin F
    J Neurol Sci; 1969; 8(3):555-61. PubMed ID: 5807290
    [No Abstract]   [Full Text] [Related]  

  • 4. [Concentration of copper and ceruloplasmin in serum of patients treated for epilepsy].
    Motta E; Miller K; Ostrowska Z
    Wiad Lek; 1998; 51(3-4):156-61. PubMed ID: 9658990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentrations of diphenylhydantoin (phenytoin) and phenobarbital and their relation to therapeutic and toxic effects.
    Buchthal F; Svensmark O
    Psychiatr Neurol Neurochir; 1971; 74(2):117-36. PubMed ID: 5004709
    [No Abstract]   [Full Text] [Related]  

  • 6. The value of serum diphenylhydantoin (phenytoin) levels in the management of epilepsy.
    Reynolds EH
    Proc R Soc Med; 1975 Feb; 68(2):102-4. PubMed ID: 1166035
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diphenylhydantoin stimulation test in Wilson's disease].
    Lössner J; Kühn HJ
    Psychiatr Neurol Med Psychol (Leipz); 1979 Sep; 31(9):525-30. PubMed ID: 538130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diphenylhydantoin dosage.
    Eadie MJ; Tyrer JH; Hooper WD
    Proc Aust Assoc Neurol; 1973; 10(0):53-9. PubMed ID: 4792162
    [No Abstract]   [Full Text] [Related]  

  • 9. Simultaneous gas liquid chromatographic dosage of phenobarbital and diphenylhydantoin in serum.
    Tedeschi L; Marigo M; Ferrara SD; Castagna F
    Farmaco Prat; 1978 Feb; 33(2):83-93. PubMed ID: 631315
    [No Abstract]   [Full Text] [Related]  

  • 10. [Control of long-term therapy with diphenylhydantoin. Gas-chromatographic determination of diphenylhydantoin and hydroxy-diphenylhydantoin].
    Mascher J; Bernhardt W
    Z Neurol; 1973 May; 204(3):179-92. PubMed ID: 4123516
    [No Abstract]   [Full Text] [Related]  

  • 11. [Determination of diphenylhydantoin (DFH) in plasma in patients with epilepsy].
    Borgå O; Lund L; Sjöqvist F
    Lakartidningen; 1969 Oct; 66():Suppl 3:89-98. PubMed ID: 5383812
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum copper levels and epilepsy.
    Brunia CH; Buyze G
    Epilepsia; 1972 Sep; 13(5):621-5. PubMed ID: 4628641
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies of anticonvulsant levels in epileptics. I. Serum diphenylhydantoin concentrations in a group of medically indigent outpatients.
    Haerer AF; Grace JB
    Acta Neurol Scand; 1969; 45(1):18-31. PubMed ID: 4979531
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of some serum copper parameters in trained runners and control subjects.
    Resina A; Fedi S; Gatteschi L; Rubenni MG; Giamberardino MA; Trabassi E; Imreh F
    Int J Sports Med; 1990 Feb; 11(1):58-60. PubMed ID: 2318564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible subacute peripheral neuropathy induced by phenytoin.
    Dobkin BH
    Arch Neurol; 1977 Mar; 34(3):189-90. PubMed ID: 190987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in serum copper and serum ceruloplasmin concentration induced by surgical trauma.
    Hallböök T; Hedelin H
    Acta Chir Scand; 1980; 146(6):371-3. PubMed ID: 7468069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of anticonvulsant level determination in the treatment of epilepsies].
    Loiseau P; Brachet-Liermain A; Legroux M; Jogeix M
    Nouv Presse Med; 1977 Mar; 6(10):813-7. PubMed ID: 322087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum ceruloplasmin-bound copper and non-ceruloplasmin copper in uncomplicated psoriasis.
    Kekki M; Koskelo P; Lassus A
    J Invest Dermatol; 1966 Aug; 47(2):159-66. PubMed ID: 5916129
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum protein binding of diphenylhydantoin in man. I. Interaction with sodium valproate.
    Lecchini S; Gatti G; De Bernardi M; Caravaggi M; Frigo GM; Calzetti S; Visintini D
    Farmaco Prat; 1978 Feb; 33(2):80-2. PubMed ID: 344060
    [No Abstract]   [Full Text] [Related]  

  • 20. Motor nerve conduction study in patients on diphenylhydantoin therapy.
    Chokroverty S; Sayeed ZA
    J Neurol Neurosurg Psychiatry; 1975 Dec; 38(12):1235-9. PubMed ID: 176326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.